Senzime AB (publ) announced that the company has contracted Erik Bergman as new CFO and member of the management team. Erik succeeds Jessica Roxhed as CFO and takes office on October 1, 2019. Erik comes from a position as CEO of the vaccine adjuvant company Novavax AB, and since autumn 2018 he has worked at Senzime to a lesser extent via his own company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.68 SEK | 0.00% | -3.61% | -10.09% |
May. 07 | Transcript : Senzime AB, Q1 2024 Earnings Call, May 07, 2024 | |
May. 07 | Senzime AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.09% | 74.68M | |
-6.23% | 181B | |
+2.59% | 114B | |
-2.75% | 68.29B | |
+5.32% | 52.24B | |
+7.61% | 44.3B | |
+5.84% | 42.73B | |
+25.17% | 32.52B | |
+17.91% | 26.02B | |
-2.66% | 25.91B |
- Stock Market
- Equities
- SEZI Stock
- News Senzime AB
- Senzime AB Contracted Erik Bergman as New CFO and Member of the Management Team